Applications are open for fall 2026!
Apply Today
David Hutton, a professor of Health Management and Policy and Global Public Health, discusses the cost-effectiveness of RSV vaccination in older adults. Hutton and a group of University of Michigan researchers recently presented research on the topic during a meeting for the CDC's Advisory Committee on Immunization Practices (ACIP).
Matthew Boulton, Senior Associate Dean for Global Public Health, was quoted in Detroit Free Press. He stated it is important for the public to be updated with their polio vaccines.
Identifying adults who are ambivalent about vaccines early in a pandemic and finding community leaders who can help spread reliable information within their communities could help reduce vaccine hesitancy, according to a new University of Michigan study.
Adding the hurdle of vaccine education prior to obtaining a nonmedical exemption may improve vaccination rates in the short term, but policymakers may want to consider more holistic strategies to change parental behaviors in the long term, according to a new University of Michigan study.
The next phase of coronavirus vaccine campaigns will require reaching Americans who have little access to the shots and those whose jobs make it difficult to take time off to get vaccinated, according to public health experts.
A recurring sentiment among some in the vaccine-hesitant community is a desire to wait to receive any of the three available COVID-19 vaccines until they have been officially approved by the Food and Drug Administration. And while the FDA has authorized the Pfizer, Moderna and Johnson & Johnson vaccines―and is expected to also approve each one in turn―for many people, the difference between “authorized” and “approved” has been confusing.